Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

991.0500 10.00 (1.02%)

NSE Sep 01, 2025 15:31 PM

Volume: 1.5M

Zydus Lifesciences Ltd.

06 Dec 2023

991.05

1.02%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives Final Approval from the USFDA for Methylene Blue Injection

More from Zydus Lifesciences Ltd.

Recommended

Market closes higher, Ashok Leyland to invest Rs 5,000 crore to develop batteries in India

Trendlyne Marketwatch | 01 Sep 2025, 03:59PM

Five Interesting Stocks Today - August 29, 2025

The Baseline | 29 Aug 2025

Earnings Call Transcript - Cadila Healthcare